retatrutide glp 1 Obesity is expected to affect nearly a quarter of the world population by 2035. Retatrutide, an investigational GIP, GLP-1, and GCG receptor agonist, holds promise for weight reduction in adults. New Retatrutide Weight Loss Results:Trial Data

Advances in nanoparticle-based therapeutics for ischemic stroke: Enhancing drug delivery and efficacy

By leveraging the inherent biocompatibility and molecular specificity of proteins, these nanoplatforms enable precise modulation of immune pathways, offering novel solutions to reinvigorate antitumor immunity

And when hydration feels easy, enjoyable, and convenient, it becomes much simpler to stay consistent

"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents." Am J Psychiatry

L-Carnitine - VIH et SIDA Le virus de l'immunodficience humaine (VIH) provoque une diminution du nombre de lymphocytes (un type de globules blancs), ce qui conduit au syndrome d'immunodficience acquise (SIDA)

Treated animals showed significantly better neurological outcomes assessed by the BBB locomotor rating scale compared to controls